September 06, 2013
Gilead Sciences to Present at Two Upcoming Investor Conferences
- 2013 Morgan Stanley Global Healthcare Conference on September 9th
-
- Baird’s 2013 Healthcare Conference on September 10th
-
- Webcast Available Through Gilead Corporate
Website -
FOSTER CITY, Calif.--(BUSINESS WIRE)--Sep. 6, 2013--
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company
will be webcasting its corporate presentation at two upcoming investor
conferences: the 2013 Morgan Stanley Global Healthcare Conference and
Baird’s 2013 Healthcare Conference, both taking place in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating Officer,
will provide an overview of the company at the Morgan Stanley conference
on Monday, September 9 at 11:10 a.m. Eastern Time (ET) and the Baird
conference on Tuesday, September 10 at 10:15 a.m. ET.
To access the live webcast or a replay via the internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast. The replay will
be available for 14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Asia
Pacific.
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
(1-800-445-3235).
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor
Relations
